MMP9 and breast carcinoma: A study demonstrated that exosome, rich in ECM degradation enzyme, transferred from MDA-MB-231 highly metastatic breast cancer cells to MCF-10A epithelial breast cancer cells (non-tumorigenic), leads to metastasis by increasing the expression of MMP-2 and MMP-9 [65,66].